VAM 19 1210: Can There Be a Universal Approach to Food Allergy Prevention Guidelines?

This course is part of the 2019 Virtual Annual Meeting. Want more virtual meeting recordings? Save by ordering the full set!

Session 1210 includes the following talks:

  • What Foods Should We be Introducing Early for Protection Against the Development of Food Allergy?
  • When Should We Start Early Introduction, and How Do We Balance This within the Developmental Trajectories of Infants and Who Breastfeeding Recommendations?
  • Should Implementation Strategies for Screening and the Role of Primary Care Differ Among Countries?
  • Has the Voice of the Stakeholder Been Heard in Understanding How to Implement Early Introduction Recommendations?
  • What Can We Offer the Family with a Child Who Fails Early Introduction?
  • Where Do We Go from Here? What Is the Next Leap in Food Allergy Prevention

The American Board of Allergy and Immunology (ABAI) has approved this activity for 3.00 MOC Part II Self-Assessment credits.  These credits will be awarded once you have completed all components of the course

Target Audience

Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the existing evidence and rationale for specific foods supporting their early introduction to reduce the risk of developing food allergy
  • Discuss the pros and cons of having allergist facilitated introduction compared to an open recommendation for all infants to have early introduction without medical intervention
  • Discuss the potential that a child may fail early introduction, and identify the psychosocial needs that such children may require given earlier diagnosis of allergy, as well as potential treatment options available for such children
Available credit: 
  • 3.00 Attendance
    Attendance credit.
  • 3.00 CE
    CE credit.
  • 3.00 CME
    CME credit.
Course opens: 
Course expires: 

Edmond Chan, MD FAAAAI
Debra Palmer, MD
Jonathan O'B. Hourihane, MD FAAAAI
Scott Sicherer, MD FAAAAI
Jennifer Koplin, PhD

Robert N. Corriel, MD FAAAAI
Shirley S. Joo, MD
Todd Rambasek, MD FAAAAI

AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:

  • Employment. Name of employer and job title.
  • Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.

Accreditation Statement

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement

The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 3.00 Contact Hours.

Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on April 30, 2021. Requests to claim credit on or after May 1, 2021 will be subject to an administrative fee.

AAAAI Privacy Policy

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at


Activity related questions should be directed to

Available Credit

  • 3.00 Attendance
    Attendance credit.
  • 3.00 CE
    CE credit.
  • 3.00 CME
    CME credit.


Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.